1. Home
  2. CORT vs KNX Comparison

CORT vs KNX Comparison

Compare CORT & KNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • KNX
  • Stock Information
  • Founded
  • CORT 1998
  • KNX 1989
  • Country
  • CORT United States
  • KNX United States
  • Employees
  • CORT N/A
  • KNX N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • KNX Trucking Freight/Courier Services
  • Sector
  • CORT Health Care
  • KNX Industrials
  • Exchange
  • CORT Nasdaq
  • KNX Nasdaq
  • Market Cap
  • CORT 7.1B
  • KNX 7.2B
  • IPO Year
  • CORT N/A
  • KNX 1994
  • Fundamental
  • Price
  • CORT $73.36
  • KNX $45.56
  • Analyst Decision
  • CORT Strong Buy
  • KNX Buy
  • Analyst Count
  • CORT 4
  • KNX 16
  • Target Price
  • CORT $142.00
  • KNX $51.47
  • AVG Volume (30 Days)
  • CORT 1.4M
  • KNX 3.2M
  • Earning Date
  • CORT 05-05-2025
  • KNX 04-23-2025
  • Dividend Yield
  • CORT N/A
  • KNX 1.58%
  • EPS Growth
  • CORT 8.36
  • KNX 37.21
  • EPS
  • CORT 1.14
  • KNX 0.93
  • Revenue
  • CORT $685,446,000.00
  • KNX $7,411,973,000.00
  • Revenue This Year
  • CORT $35.85
  • KNX $4.64
  • Revenue Next Year
  • CORT $35.22
  • KNX $7.93
  • P/E Ratio
  • CORT $64.25
  • KNX $48.86
  • Revenue Growth
  • CORT 30.93
  • KNX 1.16
  • 52 Week Low
  • CORT $25.35
  • KNX $36.69
  • 52 Week High
  • CORT $117.33
  • KNX $61.51
  • Technical
  • Relative Strength Index (RSI)
  • CORT 55.18
  • KNX 61.27
  • Support Level
  • CORT $68.86
  • KNX $45.13
  • Resistance Level
  • CORT $73.36
  • KNX $49.39
  • Average True Range (ATR)
  • CORT 3.31
  • KNX 1.36
  • MACD
  • CORT -0.08
  • KNX 0.90
  • Stochastic Oscillator
  • CORT 75.62
  • KNX 67.07

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.

About KNX Knight-Swift Transportation Holdings Inc.

Knight-Swift is the largest full-truckload carrier in the US, with a diversified transportation offering. Pro forma for the U.S. Xpress deal, about 82% of revenue derives from Knight's asset-based trucking business, with full truckload (for-hire dry van, refrigerated, and dedicated contract) making up 69% and less than truckload 13%. Truck brokerage and other asset-light logistics services make up 9% of revenue, with intermodal near 6%. Knight's intermodal operations use the Class I railroads for the underlying movement of its shipping containers and include drayage (regional trucking services to and from inland intermodal ramps/terminals). The remainder of revenue reflects services offered to shippers and third-party truckers, including equipment maintenance and leasing.

Share on Social Networks: